PHAT Q1 2024 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$1M77.7% margin

Operating Income

-$70M-3658.7% margin

Net Income

-$83M-4333.3% margin

EPS (Diluted)

$-1.42

QoQ Revenue Growth

+180.4%

Cash Flow

Operating Cash Flow

-$69M

Free Cash Flow

-$69M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$356M

Total Liabilities

$505M

Stockholders' Equity

-$149M

Cash & Equivalents

$322M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$70M	-$30M	-132.6%
Net Income	-$83M	-$38M	-119.1%